Zanamivir for inhal
Ended Awarded
- Contract number
- SPE2DP22F7811
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $7,875
Award facts
- Contract value 100% obligated
- $7,875.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
Award details come from SAM.gov/FPDS.
About this award
Glaxosmithkline, LLC was awarded a $7,875 firm fixed price delivery order against an unmentioned contract vehicle to supply zanamivir for inhalation to the Defense Logistics Agency Troop Support Medical. The delivery order has a period of performance through April 2023 and was awarded on September 27, 2022 without a set-aside designation. Glaxosmithkline will deliver the respiratory drug from its location in Research Triangle Park, North Carolina to support agency medical programs.
Quick answers
Who was awarded contract SPE2DP22F7811?
SPE2DP22F7811 was awarded to Glaxosmithkline, LLC by Medical Supply Chain (Troop Support) on September 27, 2022.
How much is contract SPE2DP22F7811 worth?
The government has obligated $7,875 on SPE2DP22F7811.
Is contract SPE2DP22F7811 an order under another contract?
Yes. SPE2DP22F7811 is a delivery order under SPE2DP22D0009, an indefinite delivery contract.
Was contract SPE2DP22F7811 competed?
The extent of competition for SPE2DP22F7811 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award